🇺🇸 FDA

Company profile · Sponsor

Hansa

Hansa Biopharma AB

ED88641 · EMA biotech EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Hansa (ED88641) is a biotech company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ED88641
Exchange EMA
Company type biotech
Headquarters EU

Pipeline (1)

Search pipeline →

  1. Idefirix 11 mg powder for concentrate for solution for infusion

    Hansa

    End stage chronic kidney disease (CKD) patients who are highly sensitised and on the kidney transplant list awaiting a kidney transplant

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Hansa?

Hansa (ED88641) is a biotech company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Hansa sponsor?

We track 1 ClinicalTrials.gov-linked program for Hansa, including Idefirix 11 mg powder for concentrate for solution for infusion. Open each program for phase, modality, NCT IDs, and indication details.

Where does Hansa company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.